Myomo Receives Popular Science "Best Of What's New" Award For NeuroRobotic Technology Innovation

Main Category: Stroke
Also Included In: Medical Devices / Diagnostics
Article Date: 14 Nov 2007 - 15:00 PST

email to a friend   printer friendly   view / write opinions   rate article

Myomo,™ Inc., a pioneer developer of a new class of non-invasive medical device technology, announced that the editors of Popular Science have named the Company's one of the top technology innovations of 2007. Myomo received a Best of What's New award in the Personal Health category for the Myomo e100 NeuroRobotic™ System, and is featured in the magazine's December issue featuring the top 100 greatest innovations in the world of science and technology.

"For 20 years, Popular Science's Best of What's New awards honor the innovations that can make a positive impact on life today and change our views of the future," says Mark Jannot, Editor-in-Chief of Popular Science. "PopSci's editors evaluate thousands of products each year to develop this thoughtful list, there's no higher accolade Popular Science can give."

The Myomo e100 NeuroRobotic System is a user-controlled, wearable, portable robotic brace designed to non-invasively treat arm dysfunction cause by stroke, the leading cause of long-term disability in the United States, affecting 700,000 people annually. Clinically shown to improve mobility in patients ranging from 4 weeks to 21 years after stroke onset, the Myomo innovation helps patients relearn how to move by enabling them to self initiate and control movement of hemiparetic (partially paralyzed) arms using their biological signals. No electrical stimulation or invasive procedures are employed.

Myomo's flagship product is built on NeuroRobotics, a platform technology that converges advances in neuroscience and robotics with scientific research that shows the brain's capacity to remap following an injury. NeuroRobotics is designed to promote motor recovery by non-invasively targeting both the neurological and muscular systems that affect motor control. Initially for upper extremity stroke motor recovery, NeuroRobotics has the potential to treat a broad range of conditions that result in loss of neurological function or atrophy.

"Everyone at Myomo is very excited to be recognized by Popular Science as a Company that is revolutionizing healthcare with NeuroRobotics technology," said Thomas Glover, Chief Executive Officer, Myomo. "We appreciate the editors' recognition of our technology's advancement in helping empower and improve the quality of life of millions of people. We are also honored to have our innovation recognized alongside such distinguished companies."

About Popular Science

Founded in 1872, Popular Science is the world's largest science and technology magazine; with a circulation of 1.3 million and 6.8 million monthly readers. Each month, Popular Science reports on the intersection of science and everyday life, with an eye toward what's new and why it matters. Popular Science is published by Bonnier Active Media, a subsidiary of Bonnier Corporation.

http://www.popsci.com/popsci

About Myomo, Inc.

Myomo, Inc. is pioneering development and commercialization of NeuroRobotics, a new class of non-invasive medical device technology, combining advances in neuroscience and robotics, to restore independence to individuals after loss of neurological function or atrophy. The Company's flagship product, the Myomo e100 NeuroRobotic System, is the first portable, wearable robotic device controllable by a patient's biological signals and is clinically shown to improve mobility in patients presenting from weeks to 21 years post onset of stroke. Designed to help individuals relearn how to move hemiparetic (partially paralyzed) arms caused by stroke, the Myomo e100 enables patient-initiated and controlled movement of affected limbs without requiring electrical stimulation or invasive procedures of any kind. Myomo's founding research was developed with assistance from the Deshpande Center for Technology Innovation and leverages proprietary knowledge from the Massachusetts Institute of Technology Active Joint Brace research and collaboration with leading clinical researchers. Myomo is a privately held medical device technology company and is headquartered in Boston, MA.

http://www.myomo.com